5 completed, 5 unknown. 10 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Unknown 5 |
| Phase 3 | 3 | Unknown 2, Completed 1 |
Follow Levamisole: new trials by email Literature Review of Levamisole trials Research Report on Levamisole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis | Phase 2 / Phase 3 | Unknown | Programme National de Lutte contre l'Onchocercose, Republic of the Congo | 99 | 2024-06-21 | 2024-09-20 |
| Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients LEV 1 mg/kg, LEV 1,5 mg/kg, LEV 2,5 mg/kg - Onchocerciasis, Ocular, Loiasis | Phase 2 | Completed | Programme National de Lutte contre l'Onchocercose, Republic of the Congo | 255 | 2021-01-16 | 2021-09-20 |
| Pharmacological Modulation of Hippocampal Activity in Psychosis 2 Levetiracetam (LEV) 500 mg, Placebo - Schizophrenia; Psychosis | Phase 2 | Completed | Vanderbilt University Medical Center | 62 | 2020-09-23 | 2024-02-05 |
| Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 Levamisole Pill + Budesonide+Formoterol inhaler, Lopinavir/Ritonavir + hydoxychloroquine - COVID-19 | Phase 2 / Phase 3 | Unknown | Fasa University of Medical Sciences | 30 | 2020-04-04 | 2020-04-13 |
| A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia rabbit ATG, Cyclosporine, Levamisole - Aplastic Anemia | Phase 2 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 40 | 2014-08-01 | 2026-02-11 |
| Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) Levamisole+cyclosporin A+Glucocorticoids, cyclosporin A+Glucocorticoids, Glucocorticoids - Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria | Phase 2 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 50 | 2013-01-01 | 2013-01-03 |
| Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria Levamisole+cyclosporin A+Glucocorticoids, cyclosporin A+Glucocorticoids, Glucocorticoids - Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria | Phase 2 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 120 | 2012-07-01 | 2013-01-03 |
| Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. levamisole, Prednisone - Anemia, Anemia, Hemolytic | Phase 2 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 100 | 2012-04-01 | 2012-04-19 |
| Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne Levamisole - Acne | Phase 2 / Phase 3 | Completed | Ahvaz Jundishapur University of Medical Sciences | 169 | 2008-11-01 | 2011-05-05 |
| Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients Levamisole, Placebo - Renal Dialysis | Phase 2 | Completed | Shiraz University of Medical Sciences | 40 | 2008-03-01 | 2013-07-26 |
Anemia (3) · Anemia, Aplastic (3) · Anemia, Hemolytic (3) · Hematologic Diseases (3) · Bone Marrow Failure Disorders (2) · Hemoglobinuria (2) · Hemoglobinuria, Paroxysmal (2) · Loiasis (2) · Proteinuria (2) · Thrombosis (2) · Urination Disorders (2) · Acne Vulgaris (1) · Anemia, Hemolytic, Autoimmune (1) · Autoimmune Diseases (1) · COVID-19 (1)
Institute of Hematology & Blood Diseases Hospital, China (4) · Programme National de Lutte contre l'Onchocercose, Republic of the Congo (2) · Ahvaz Jundishapur University of Medical Sciences (1) · Fasa University of Medical Sciences (1) · Shiraz University of Medical Sciences (1) · Vanderbilt University Medical Center (1)
China (4) · Iran (3) · Republic of the Congo (2) · United States (1)
Mohamad Mahdi Sagheb, MD (1) · Siamack Afazeli (1) · Sima Rasaii, Dermtologist (1) · Stephan Heckers, MD (1) · Yizhou Zheng, doctor (1) · Zheng Yizhou, M.D., Ph.D (1)
PMID 1090310, PMID 12622583, PMID 18720689, PMID 23547851, PMID 24341659, PMID 32738928, PMID 34651190, PMID 40615414